MiMedx Group, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6024961012
USD
4.41
0.03 (0.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
MiMedx Group, Inc.
LeMaitre Vascular, Inc.
Stevanato Group SpA
Establishment Labs Holdings, Inc.
Tandem Diabetes Care, Inc.
Paragon 28, Inc.
Alphatec Holdings, Inc.
Avanos Medical, Inc.
Myriad Genetics, Inc.
Quanterix Corp.
Owens & Minor, Inc.

Why is MiMedx Group, Inc. ?

1
Company has a low Debt to Equity ratio (avg) at times
2
Low Debt Company with Strong Long Term Fundamental Strength
  • OPERATING CASH FLOW(Y) Highest at USD 68.93 MM
  • RAW MATERIAL COST(Y) Fallen by -2.36% (YoY)
  • CASH AND EQV(HY) Highest at USD 260.95 MM
3
With ROE of 17.11%, it has a attractive valuation with a 2.76 Price to Book Value
  • Over the past year, while the stock has generated a return of -44.32%, its profits have fallen by -52.5%
4
High Institutional Holdings at 75.64%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 2.32% over the previous quarter.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to MiMedx Group, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is MiMedx Group, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
MiMedx Group, Inc.
-44.32%
-0.91
40.44%
S&P 500
18.81%
0.98
19.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.97%
EBIT Growth (5y)
29.05%
EBIT to Interest (avg)
3.60
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
1.79
Tax Ratio
26.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
75.64%
ROCE (avg)
16.68%
ROE (avg)
13.42%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.76
EV to EBIT
9.91
EV to EBITDA
8.06
EV to Capital Employed
4.65
EV to Sales
1.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
46.89%
ROE (Latest)
17.11%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 68.93 MM

RAW MATERIAL COST(Y)

Fallen by -2.36% (YoY

CASH AND EQV(HY)

Highest at USD 260.95 MM

DEBT-EQUITY RATIO (HY)

Lowest at -51.84 %

NET SALES(Q)

Highest at USD 113.72 MM

OPERATING PROFIT(Q)

Highest at USD 27.48 MM

OPERATING PROFIT MARGIN(Q)

Highest at 24.16 %

PRE-TAX PROFIT(Q)

Highest at USD 22.85 MM

NET PROFIT(Q)

Highest at USD 16.75 MM

EPS(Q)

Highest at USD 0.11

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for MiMedx Group, Inc.

Operating Cash Flow
Highest at USD 68.93 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Pre-Tax Profit
At USD 22.85 MM has Grown at 104.56%
over average net sales of the previous four periods of USD 11.17 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 16.75 MM has Grown at 107.89%
over average net sales of the previous four periods of USD 8.06 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
Highest at USD 113.72 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 113.72 MM has Grown at 25.05%
over average net sales of the previous four periods of USD 90.94 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 27.48 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 24.16 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 22.85 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 16.75 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.11
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv
Highest at USD 260.95 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -51.84 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -2.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 5.29 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation
At USD 5.29 MM has Grown at 67.19%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)